Kazia Therapeutics Ltd
Research Kazia Therapeutics Ltd (KZIA) on Bullrun: market cap USD 102.04M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerKZIA
- ExchangeNASDAQ
- CountryAustralia
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 102.04M
- Financial periodFY2025
- RevenueAUD 42.00K
- Revenue growth-98.2%
- Net income-AUD 20.70M
- Free cash flow-AUD 13.28M
- Gross margin4357.1%
Valuation Snapshot
latest market cap is USD 102.04M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | AUD 42.00K | -AUD 20.70M | -AUD 13.28M | 4357.1% | -18.9 | AUD 4.35M | AUD 396.00K | -AUD 8.30M |
| FY2024 | AUD 2.31M | -AUD 26.78M | -AUD 9.58M | 107.5% | -50.8 | AUD 1.66M | AUD 634.00K | -AUD 10.02M |
| FY2023 | AUD 0 | -AUD 20.47M | -AUD 15.16M | n/a | -56.15 | AUD 5.24M | AUD 1.80M | AUD 12.05M |
| FY2022 | AUD 0 | -AUD 25.01M | -AUD 22.76M | n/a | -93.05 | AUD 7.36M | AUD 1.84M | AUD 18.28M |
| FY2021 | AUD 15.18M | -AUD 8.42M | -AUD 9.11M | 100.0% | -35.8 | AUD 27.59M | n/a | AUD 37.85M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 102.04M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 78.11M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 8.56M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 11.60M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 9.22M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 111.19M | n/a | n/a | n/a |
About Kazia Therapeutics Ltd
Kazia Therapeutics Limited, together with its subsidiaries, operates as an oncology-focused biotechnology company in Israel. The company's lead development candidate is paxalisib, a small molecule, brain-penetrant inhibitor of the phosphoinositide-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway, which is in Phase II/III clinical trial for the treatment of glioblastoma;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Kazia Therapeutics Ltd's market cap?
Kazia Therapeutics Ltd's market capitalization is USD 102.04M.
What does Kazia Therapeutics Ltd do?
Kazia Therapeutics Limited, together with its subsidiaries, operates as an oncology-focused biotechnology company in Israel.